Nurix Therapeutics Inc (NRIX)

Currency in USD
11.88
-0.01(-0.08%)
Closed·
After Hours
11.23-0.65(-5.47%)
·

NRIX Financial Summary

Key Ratios

P/E Ratio-4.87
Price/Book2.16
Debt / Equity11.6%
Return on Equity-50.67%
Dividend Yield0.00%
EBITDA-205.01M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2018
30/11
2019
30/11
2020
30/11
2021
30/11
2022
30/11
2023
30/11
2024
30/11
* In Millions of USD (except for per share items)

Analyst Ratings

16 Buy
2 Hold
0 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 29.83
(+151.12% Upside)

Earnings

Latest Release
Jul 09, 2025
EPS / Forecast
-0.52 / -0.714
Revenue / Forecast
44.06M / 16.90M
EPS Revisions
Last 90 days

FAQ

What were Nurix's earnings for the latest quarter?

The Nurix EPS (TTM) is -2.60. Nurix reported sales of 44.06, net income of -43.46, and EPS of -0.52 for the latest quarter.

What was Nurix's net income for the latest quarter?

Nurix's net income for the latest quarter was -43.46.

How did Nurix's performance compare year-over-year in the latest quarter?

The company's revenue moved from 18.45 in the previous quarter to 44.06 in the latest quarter, and net income moved from -56.35 to -43.46 compared to the previous quarter.

What is Nurix's net profit margin on a TTM basis?

Nurix's trailing twelve months (TTM) net profit margin is -354.85%.

How does Nurix's debt to equity ratio compare to industry standards?

Nurix's total debt-to-equity ratio is 11.60%.

What is Nurix's return on investment on a TTM basis?

Nurix's trailing twelve months (TTM) return on investment (ROI) is -50.67%.

Did Nurix gain or lose cash last quarter?

In the latest quarter, Nurix's net change in cash was 8.34 million.

What were Nurix's total assets and liabilities in the latest quarter?

As of the latest quarter, Nurix reported total assets of 591.56 million and total liabilities of 75.61 million.

How has Nurix's total revenue grown this year?

Nurix's total revenue was 18.45 in the previous quarter and 44.06 in the latest quarter.

What is Nurix's gross margin on a TTM basis?

Nurix's trailing twelve months (TTM) gross margin is -206.02%.

What was Nurix's revenue per share for the latest quarter?

Nurix's revenue per share for the latest quarter was 3.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.